Medicines

NICE recommends Tremfya

NICE has approved Tremfya (guselkumab) for the treatment of adults with moderate to severe plaque psoriasis

Paracetamol, pregnancy and language

Exposure to paracetamol during pregnancy seems to increase the risk of language delay in girls, but not boys

Warfarin may cut cancer risk

Research suggests warfarin may have anti-cancer potential. Could this have implications for anticoagulation patients?

Tremfya launched for psoriasis

Janssen has launched guselkumab (Tremfya) for adults with moderate to severe plaque psoriasis

Quadrivalent flu jab launched

Sanofi Pasteur recently launched a quadrivalent influenza vaccine in the UK that protects against two A and two B strains

New antibiotic launched

Pfizer has launched Zavicefta (ceftazidime-avibactam) for adults hospitalised with serious infections

Verapamil for rhinosinusitis?

Verapamil dramatically improves symptom scores in patients with chronic rhinosinusitis and nasal polyps

NSAIDs and paracetamol linked to hearing loss

NSAIDs and paracetamol might increase the risk of hearing loss, according to an analysis of 55,850 women

Rotavirus vaccine is preventing gastroenteritis in infants

Infant rotavirus vaccine reduces the number of episodes of acute gastroenteritis by up to half and saves £12.5m a year

Teva launches reformulated levothyroxine range

Teva has launched a reformulated version of levothyroxine, including two previously unavailable strengths

Xultophy approved for renal impairment

Xultophy has been approved for adults with type 2 diabetes and moderate renal impairment

Update: media scare stories cutting statin use?

Media stories questioning the safety of statins are causing people to stop taking the drugs

Update: Enstilar – new psoriasis drug

Enstilar (calcipotriol and betamethasone dipropionate) is a new topical, alcohol-free, foam spray for plaque psoriasis

Massive increase in ADHD prescribing

Prescriptions for ADHD drugs in the UK increased by almost 800 per cent between 2000 and 2015

Benzodiazepines could significantly increase flu risk

Benzodiazepines may increase mortality more than 20-fold in people with influenza-like illness, new research finds

Actavis adds gliclazide 40mg

Actavis has added gliclazide 40mg tablets alongside the existing 80mg tablet offer

New ticagrelor dose

Marketing authorisation has been granted for a 60mg dose of ticagrelor for patients who have suffered a heart attack  

New lung cancer drug

The European Commission has granted marketing authorisation for necitumumab (Portrazza) for lung cancer

Ezetimibe indication widened

The MHRA recently extended the indication for ezetimibe (Ezetrol)

Dementia script numbers rise but costs fall

The number of prescriptions for drugs for Alzheimer’s disease rose more than six-fold over the past decade
Previous 1 2 3 4 Next

Latest

Gearing up for the flu vaccination 2018-19

Information and promotional resources to support the 2018-19 flu vaccination programme are becoming available, including...

Consultation on dispensing errors and responsible pharmacist role

A UK-wide consultation was launched in mid-June on two new draft pieces of legislation covering dispensing errors and ph...

Views

NAO investigation and RPS report on mental health – some reflec…

By Richard Thomas, editor, Pharmacy Magazine. This month saw the publication of two major reports, polar opposites in t...

Popular

Train your team: Hayfever

This Train Your Team checklist provides information to run a training session on that seasonal scourge, hayfever

Phoenix on track to update its van fleet

Phoenix Healthcare Distribution has announced the roll out of 39 new vans designed to exceed current GDP standards, incl...

Pet health: Paws for thought

With 12 million households owning at least one pet there is an opportunity for pharmacy to provide these customers with ...


By using this website, you accept Pharmacy Magazine Terms of Use, Privacy Policy and Cookie Policy. Click accept to hide box. By continuing browsing you have confirmed your acceptance.